A Study to Evaluate the Pharmacokinetics and Bioequivalence of Sumatriptan Delivered Via the Intraject System
PHASE1CompletedINTERVENTIONAL
Enrollment
54
Participants
Timeline
Start Date
December 31, 2006
Primary Completion Date
December 31, 2006
Conditions
PharmacokineticsBioequivalence
Interventions
DEVICE
Sumatriptan (via Intraject System)
0.5 mL of solution with 6 mg of sumatriptan (base) as the succinate salt
Trial Locations (1)
75247
Covance, Inc, Dallas
All Listed Sponsors
lead
Zogenix, Inc.
INDUSTRY
NCT00614029 - A Study to Evaluate the Pharmacokinetics and Bioequivalence of Sumatriptan Delivered Via the Intraject System | Biotech Hunter | Biotech Hunter